Home › Calculator › IOVA Dividend Calculator 2026
IOVA Dividend DRIP Calculator 2026
40.08% YieldHealthcareIovance Biotherapeutics, Inc. · NASDAQ
Price: $4.99 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When IOVA pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your IOVA snowball 📈
$10,000 in IOVA → $290.9K in 10 years · $6,936.46/month
About Iovance Biotherapeutics, Inc. (IOVA) — Dividend Analysis 2026
Iovance Biotherapeutics, Inc., a biotechnology firm currently in the clinical development stage, is committed to discovering and bringing to market cancer immunotherapy solutions. Its core mission involves leveraging the patient's own immune system to effectively combat and eradicate cancerous cells. The company is presently conducting six Phase 2 clinical trials. These include study C-144-01, evaluating its primary experimental compound, lifileucel, for individuals with advanced melanoma. Another trial, C-145-04, is assessing lifileucel's potential for treating cervical cancer that is recurrent, metastatic, or persistent. Additionally, investigational product LN-145 is undergoing evaluation in trial C-145-03 for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc. maintains strategic alliances and licensing arrangements with several distinguished entities, including H. Lee Moffitt Cancer Center, M.D. Anderson Cancer Center, Ohio State University, the Centre hospitalier de l'Université de Montreal, Cellectis S.A., and Novartis Pharma AG. Established in 2007, the company was previously known as Lion Biotechnologies, Inc. It adopted its current name, Iovance Biotherapeutics, Inc., in June 2017. Its corporate offices are located in San Carlos, California.
Compare IOVA with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full IOVA DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open IOVA position with:
🌍 IOVA Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold IOVA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 40.08% | 37.28% | $4,008 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 34.07% | 31.27% | $3,407 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 32.06% | 29.26% | $3,206 / yr |
| 🇬🇧 UK ISA | 0% | 40.08% | 37.28% | $4,008 / yr |
| 🇬🇧 UK Taxable | 8.75% | 36.57% | 33.77% | $3,657 / yr |
| 🇨🇦 TFSA | 0% | 40.08% | 37.28% | $4,008 / yr |
| 🇨🇦 CA Taxable | 25% | 30.06% | 27.26% | $3,006 / yr |
| 🇦🇺 Super (pension) | 15% | 34.07% | 31.27% | $3,407 / yr |
| 🇦🇺 AU Taxable | 30% | 28.06% | 25.26% | $2,806 / yr |
| 🇩🇪 DE Taxable | 26.375% | 29.51% | 26.71% | $2,951 / yr |
| 🇫🇷 FR Taxable | 30% | 28.06% | 25.26% | $2,806 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 IOVA Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 IOVA Dividend Payment Schedule
IOVA pays quarterly — 4 times per year. Next ex-div: TBD.
📊 IOVA vs Healthcare Benchmarks
How IOVA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for IOVA sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ IOVA Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-16 | 90,316 | — | — | ||
| A-Award | 2026-06-16 | 180,632 | — | — | ||
| A-Award | 2026-06-16 | 90,316 | — | — | ||
| A-Award | 2026-06-16 | 90,316 | — | — | ||
| A-Award | 2026-06-16 | 15,000 | — | — | ||
| M-Exempt | 2026-06-05 | 15,625 | — | — | ||
| F-InKind | 2026-06-05 | 6,638 | $4.23 | $28.1K | ||
| M-Exempt | 2026-06-05 | 15,625 | — | — | ||
| M-Exempt | 2026-06-05 | 7,813 | — | — | ||
| F-InKind | 2026-06-05 | 3,976 | $4.23 | $16.8K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where IOVA earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the IOVA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Iovance Biotherapeutics, Inc. (IOVA) is currently trading at $4.99, 89% below its 52-week high. The current dividend yield is 40.08% based on an annual payout of $2.00 per share.
IOVA (Iovance Biotherapeutics, Inc.) — 40.08% Dividend Yield Analysis
Iovance Biotherapeutics, Inc. (IOVA) is a healthcare stock currently trading at $4.99 with a dividend yield of 40.08%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (40.08%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest IOVA News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.